Autopsy report · NCT01587261
Vitamin C for Severe Thermal Injuries
Cause of deathRegulatory or ethics
“This potential study was held up at the level of the FDA as they wouldn't approve and IND for the dose of vitamin C we wanted to use.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Severe Thermal Injury, Greater Than 20% TBSA
- Interventions
- Vitamin C; Placebo
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety of SP-420 in the Treatment of Transfusional Iron Overload
“Study is on hold by FDA in the US.” - MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly
“FDA hold on the project” - Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
“The study stopped due to marketing approval by the FDA.” - Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design
“This study was closed before accrual due to FDA recall of Medication” - A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
“study intervention was approved by the FDA”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.